The present invention relates to compounds, methods and pharmaceutical compositions for inhibiting proteases, particularly serine proteases, and more particularly HCV NS3 proteases. The compounds, and the compositions and methods that utilize them, can be used, either alone or in combination to inhibit viruses, particularly HCV virus.
本发明涉及用于抑制
蛋白酶,特别是
丝氨酸蛋白酶,尤其是 HCV
NS3 蛋白酶的化合物、方法和药物组合物。这些化合物以及利用它们的组合物和方法可单独或联合用于抑制病毒,特别是 HCV 病毒。